Maaynei Hayesha Medical Center
9
0
1
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
2-Year Study of Vagus Nerve Stimulation for Higher-Grade Treatment-Resistant Depression: Clinical Outcomes and Policy Recommendation
Role: collaborator
Use of Nitrous Oxide During Office Hysteroscopy
Role: lead
COVID 19 ANTOBODIES IN PREGNANT WOMEN AND THEIR CONNECTION TO BETA CELL FUNCTION IN THE FETUS
Role: lead
The Influence of Hearing Discrete Phonemes in Mother's Voice in the Infant's Natural Environment and With Natural Melody on Developing Phonetic Categories Between 4-10 Months Old
Role: lead
Obstetrical Risk Factors for the Development of Urinary and/or Fecal Incontinence
Role: lead
Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome
Role: lead
The Effect of Spermatic Vein Embolization on Prostatic Hypertrophy
Role: lead
Sclerotherapy of Internal Spermatic Veins in Patients With Varicocele and Localized Prostate Cancer
Role: lead
Evaluation of a New Blood Pressure Measuring Device.
Role: lead
All 9 trials loaded